Specific anti-M leprae PGL-I antibodies and Mitsuda reaction in the management of household contacts in New Caledonia
- PMID: 2681462
Specific anti-M leprae PGL-I antibodies and Mitsuda reaction in the management of household contacts in New Caledonia
Abstract
Household contacts of leprosy patients have been tested for anti-phenolic glycolipid-I IgM antibodies (anti-PGL-I IgM) by an ELISA using the natural disaccharide (NDO) and natural trisaccharide (NTO) synthetic antigens. A group of healthy subjects without known exposure to Mycobacterium leprae served as controls. The percentages of positivity observed in multibacillary patients, paucibacillary patients, and household contacts were significantly higher than those of the negative controls. The absorbance values using NDO and NTO correlated well (range 0.59-0.91) when analysis of each subject group was performed. As reported here, NDO and NTO antigens seem to be equal in detecting leprosy cases; 100% of multibacillary and 21.43% of paucibacillary cases were detected as seropositive. For the screening of household contacts, NDO appears to be more sensitive and NTO more specific. There were more seropositive cases in the young age groups of household contacts, suggesting a higher rate of transmission of M. leprae infection in those age groups. Lepromin and anti-PGL-I IgG tests were also performed in contacts who were followed. The 2 paucibacillary subjects (1 borderline tuberculoid, 1 indeterminate) were Mitsuda negative. At diagnosis, their anti-PGL-I IgM levels were much higher than those of previous results; their anti-PGL-I IgG levels showed an increase in one and a decrease in the other. However, for the entire group anti-PGL-I IgM and anti-PGL-I IgG levels were positively correlated. The data reported here suggest that an increase in specific anti-M. leprae IgM levels in Mitsuda-negative household contacts could reveal the development of overt disease.
Similar articles
-
Use of anti-M. leprae phenolic glycolipid-I antibody detection for early diagnosis and prognosis of leprosy.Int J Lepr Other Mycobact Dis. 1988 Dec;56(4):527-35. Int J Lepr Other Mycobact Dis. 1988. PMID: 3065419
-
Antibodies to a synthetic analog of phenolic glycolipid-I of Mycobacterium leprae in healthy household contacts of patients with leprosy.Int J Lepr Other Mycobact Dis. 1987 Dec;55(4):617-25. Int J Lepr Other Mycobact Dis. 1987. PMID: 3323365
-
Serum IgA1 and IgM antibodies against Mycobacterium leprae-derived phenolic glycolipid-I: a comparative study in leprosy patients and their contacts.Int J Lepr Other Mycobact Dis. 1991 Sep;59(3):441-9. Int J Lepr Other Mycobact Dis. 1991. PMID: 1890368
-
The role of Mycobacterium leprae phenolic glycolipid I (PGL-I) in serodiagnosis and in the pathogenesis of leprosy.Lepr Rev. 2011 Dec;82(4):344-57. Lepr Rev. 2011. PMID: 22439275 Review.
-
HLA and leprosy in the pre and postgenomic eras.Hum Immunol. 2006 Jun;67(6):439-45. doi: 10.1016/j.humimm.2006.03.009. Epub 2006 Apr 3. Hum Immunol. 2006. PMID: 16728267 Review.
Cited by
-
Detection of anti-M. leprae antibodies in children in leprosy-endemic areas: A systematic review.PLoS Negl Trop Dis. 2021 Aug 27;15(8):e0009667. doi: 10.1371/journal.pntd.0009667. eCollection 2021 Aug. PLoS Negl Trop Dis. 2021. PMID: 34449763 Free PMC article.
-
Use of protein microarrays to define the humoral immune response in leprosy patients and identification of disease-state-specific antigenic profiles.Infect Immun. 2006 Nov;74(11):6458-66. doi: 10.1128/IAI.00041-06. Epub 2006 Sep 11. Infect Immun. 2006. PMID: 16966411 Free PMC article.
-
Prospects for new leprosy diagnostic tools, a narrative review considering ELISA and PCR assays.Rev Soc Bras Med Trop. 2020 Nov 25;53:e20200197. doi: 10.1590/0037-8682-0197-2020. eCollection 2020. Rev Soc Bras Med Trop. 2020. PMID: 33263683 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Research Materials